Companies / PAVmed Inc.

PAVmed Inc.

Nasdaq: PAVMCIK 1624326NEW YORK, NY

Financials · FY2025

Revenue$71.0K
Net income$-2.47M
Total debt—
Cash$3.78M
Diluted EPS$-5.63
Shares outstanding7.3M

Ownership

7.3M shares outstanding · as of May 12, 2026
2.6%Insiders
Ownership
Insiders2.57%186,695
Institutions1.29%94,030
Public float96.14%6,992,014

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
McGrath Dennis MPresident and CFO
2.57%186,695

Institutional holders 6

View all →
HolderValue% of shares
Geode Capital Management, LLC$119.5K0.16%
BlackRock, Inc.$101.5K0.24%
Captrust Financial Advisors$14.4K0.89%
SBI Securities Co., Ltd.$24<0.01%
BNP Paribas Financial Markets$10<0.01%
AdvisorNet Financial, Inc$1<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 2, 2026McGrath Dennis M
Executive
GrantCommon stock$0+180K
+2688.57%
186,695
2.57% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PAVMCommon StockEquity70387R502BBG00DGWP2L8